B Calesnick

694 total citations
39 papers, 528 citations indexed

About

B Calesnick is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, B Calesnick has authored 39 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in B Calesnick's work include Respiratory and Cough-Related Research (3 papers), Amino Acid Enzymes and Metabolism (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). B Calesnick is often cited by papers focused on Respiratory and Cough-Related Research (3 papers), Amino Acid Enzymes and Metabolism (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). B Calesnick collaborates with scholars based in United States. B Calesnick's co-authors include Jim Black, Dennis Williams, Melvin Weinstein, Michael Richter, J. A. Christensen, J.K. Miller, H. Hücker, Samson Symchowicz, I.I.A. Tabachnick and Arthur W. Wase and has published in prestigious journals such as Science, JAMA and Endocrinology.

In The Last Decade

B Calesnick

33 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Calesnick United States 11 150 103 71 60 60 39 528
A. J. McLean Australia 17 142 0.9× 133 1.3× 110 1.5× 80 1.3× 82 1.4× 45 914
Donald G. Corby United States 13 82 0.5× 49 0.5× 65 0.9× 92 1.5× 43 0.7× 30 685
T. Taylor United States 23 196 1.3× 109 1.1× 22 0.3× 60 1.0× 19 0.3× 75 1.1k
S. C. Sharma India 17 72 0.5× 98 1.0× 95 1.3× 16 0.3× 42 0.7× 50 769
Wendell T. Caraway United States 11 45 0.3× 170 1.7× 37 0.5× 57 0.9× 70 1.2× 23 933
Morris Pfeffer United States 14 206 1.4× 97 0.9× 14 0.2× 73 1.2× 26 0.4× 20 634
Rita C. Wright United States 14 79 0.5× 117 1.1× 28 0.4× 22 0.4× 38 0.6× 30 492
J. Rieder Austria 19 179 1.2× 119 1.2× 68 1.0× 94 1.6× 8 0.1× 43 856
Birgitta Jalling Sweden 14 141 0.9× 79 0.8× 59 0.8× 356 5.9× 18 0.3× 19 727
T. H. Peirce United States 7 80 0.5× 102 1.0× 73 1.0× 17 0.3× 15 0.3× 13 365

Countries citing papers authored by B Calesnick

Since Specialization
Citations

This map shows the geographic impact of B Calesnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Calesnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Calesnick more than expected).

Fields of papers citing papers by B Calesnick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Calesnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Calesnick. The network helps show where B Calesnick may publish in the future.

Co-authorship network of co-authors of B Calesnick

This figure shows the co-authorship network connecting the top 25 collaborators of B Calesnick. A scholar is included among the top collaborators of B Calesnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Calesnick. B Calesnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calesnick, B. (1998). Effectiveness of oral erythromycin propionate in commonly occurring infections.. PubMed. 7. 819–22.
2.
Calesnick, B. (1990). Selegiline for Parkinson's disease.. PubMed. 41(2). 589–91. 3 indexed citations
3.
Calesnick, B, et al.. (1988). Zinc deficiency and zinc toxicity.. PubMed. 37(4). 267–70. 25 indexed citations
4.
Calesnick, B. (1975). Percutaneous absorption of hexachlorophene following daily whole body washings. Toxicology and Applied Pharmacology. 32(1). 204–211. 4 indexed citations
5.
Osterholm, Jewell L., et al.. (1973). Anti-norepinephrine Therapy Against Traumatic Hemorrhagic Necrosis of the Spinal Cord: Preliminary Report. Neurosurgery. 20(Supplement 1). 382–399. 10 indexed citations
6.
Calesnick, B. (1973). Evaluation of Drug Safety and Efficacy. Hexachlorophene: Case in Point. PubMed. 13(11). 437–437.
7.
Ferko, A & B Calesnick. (1971). L-DOPA and dopamine on skeletal muscle.. PubMed. 2(2). 146–53. 5 indexed citations
8.
Calesnick, B, et al.. (1971). Antitussive Activity of Ethanol. Quarterly Journal of Studies on Alcohol. 32(2). 434–441. 5 indexed citations
9.
Hücker, H., et al.. (1967). STUDIES ON THE ABSORPTION, EXCRETION AND METABOLISM OF DIMETHYLSULFOXIDE (DMSO) IN MAN. Journal of Pharmacology and Experimental Therapeutics. 155(2). 309–317. 70 indexed citations
10.
Calesnick, B, et al.. (1967). Human Toxicity of Various Oximes. Archives of Environmental Health An International Journal. 15(5). 599–608. 55 indexed citations
11.
Calesnick, B, et al.. (1966). Absorption and Excretion of Furosemide-S35 in Human Subjects. Experimental Biology and Medicine. 123(1). 17–22. 38 indexed citations
12.
Calesnick, B. (1965). INFLUENCE OF METHYL-DOPA ON TRYPTOPHAN-LOADING TESTS IN HYPERTENSIVE PATIENTS.. PubMed. 154. 161–70. 1 indexed citations
13.
Calesnick, B & Arthur W. Wase. (1963). Absorption and excretion of radioactive Hg 203 mercaptomerin sodium in humans.. PubMed. 4. 29–34. 2 indexed citations
14.
Calesnick, B, et al.. (1962). Antidiuretic Effect of Subnarcotic Doses of Phenazocine. Anesthesiology. 23(1). 81–85.
15.
Calesnick, B, et al.. (1961). Physicochemical and Pharmacological Properties of Beef Muscle Hydrolysate. Journal of Pharmaceutical Sciences. 50(3). 268–269. 1 indexed citations
16.
Calesnick, B, et al.. (1961). 156 Direct comparison of 14C-guanethidine (Ismelin) excretion following oral and subcutaneous administration. Biochemical Pharmacology. 8(1). 49–49. 2 indexed citations
17.
Calesnick, B, et al.. (1960). DECREASE IN AEROBIC GLYCOLYSIS OF ERYTHROCYTES FOLLOWING THE CONTINUOUS ADMINISTRATION OF L-TRIIODOTHYRONINE12. Endocrinology. 66(4). 517–520. 3 indexed citations
18.
Calesnick, B, et al.. (1954). Antithyroid Action of Antibiotics. Science. 119(3082). 128–129. 19 indexed citations
19.
Calesnick, B, et al.. (1952). Hematologic therapy; some recent advances.. PubMed. 7(6). 197–201. 1 indexed citations
20.
Calesnick, B, et al.. (1951). COMBINED ACTION OF CARDIOTOXIC DRUGS: A STUDY ON THE ACUTE TOXICITY OF COMBINED QUINIDINE, MEPERIDINE, PENTOBARBITAL, PROCAINE AND PROCAINE AMIDE. Journal of Pharmacology and Experimental Therapeutics. 102(2). 138–143. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. J. McLean Breakdown of academic impact, for papers by Donald G. Corby Breakdown of academic impact, for papers by T. Taylor Breakdown of academic impact, for papers by S. C. Sharma Breakdown of academic impact, for papers by Wendell T. Caraway Breakdown of academic impact, for papers by Morris Pfeffer Breakdown of academic impact, for papers by Rita C. Wright Breakdown of academic impact, for papers by J. Rieder Breakdown of academic impact, for papers by Birgitta Jalling Breakdown of academic impact, for papers by T. H. Peirce
Rankless by CCL
2026